Annual report [Section 13 and 15(d), not S-K Item 405]

COMMITMENTS AND CONTINGENCIES (Details Narrative)

v3.25.1
COMMITMENTS AND CONTINGENCIES (Details Narrative)
12 Months Ended
Jul. 12, 2017
USD ($)
Number
Jun. 12, 2017
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
General and administrative expenses     $ 10,687,000 $ 14,891,000
Standby Letters of Credit [Member]        
Standby letter of credit, amount       10,000,000
General and administrative expenses       $ 650,000
Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] | API Supply Agreement [Member]        
Proceeds from supply agreement   $ 31,800,000    
Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] | API Supply Agreement [Member] | PGLG [Member]        
Percentage of right to supply   25.00%    
Agreement term   15 years    
Telcon RF Pharmaceuticals, Inc. ("Telcon") [Member] | Revised API Agreement [Member]        
Agreement term 5 years      
Number of renewals | Number 10      
Cumulative purchase amount $ 47,000,000      
Annual purchase target amount 5,000,000      
Target profit $ 2,500,000